Background:
Liver enzymes elevations (LEE) can be observed after kidney transplantation due to multifactorial causes.
Official Journal of Research Center for Gastroenterology and Liver Diseases
Authors
Liver enzymes elevations (LEE) can be observed after kidney transplantation due to multifactorial causes.
We performed a retrospective study on 1589 kidney transplants, 971 male and 618 female, who were hepatitis B surface antigen (HBsAg) and hepatitis C virus-antibody (HCV Ab) negative, and had no other liver diseases, to detect the prevalence of LEE and its risk factors in these patients between May 2008 and May 2010.
Liver enzymes and other biochemical parameters were measured in all recipients. Patients were divided into three groups, according to laboratory test time since transplantation: Group I, less than 3 months, Group II, 4 - 12 months after transplantation, and Group III, more than one year post-transplantation.
The highest LEE was more frequent in older patients (P < 0.001) and male individuals (P < 0.001). Aspartate aminotransferase (AST) and alanine aminotransferase (ALT) levels were higher in patients who received kidneys from deceased donors (10.4% and 23.8%, respectively) as compared to living donor transplants (5.6% and 14.8%, respectively) (P < 0.001). The elevation of ALT was the liver enzyme abnormality after kidney transplantation with the highest prevalence (34.3%). The levels of ALT and AST were significantly elevated within the first 3 months after transplantation, followed by the 4-12 months period (P < 0.001). There was a reverse correlation between liver enzyme levels and renal allograft function in both univariate and linear regression analyses. This correlation increased over time. There was also a significant relation between cyclosporine blood levels and liver enzyme values in the univariate analysis. However, this relationship was attenuated over time. Elevated liver enzymes also correlated with anemia.
The LEE is a common finding among kidney transplant recipients. Serial monitoring of aminotransferases, particularly ALT, should be performed in all patients after kidney transplantation.
© 2014, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.
Fakhar N, Nikeghbalian S, Kazemi K, Shamsayeefar AR, Gholami S, et al. Transplantation of Deceased Donor Livers With Elevated Levels of Serum Transaminases at Shiraz Transplant Center. Hepat Mon. 2016;16(10):e40140. doi: https://doi.org/10.5812/hepatmon.40140
Sabouri S, Afzal Aghaee M, Lotfi Z, Esmaily H, Alizadeh M, et al. Evaluation of Liver Enzymes in End-Stage Renal Disease Patients on the Renal Transplant-Waiting List in North-West of Iran. Nephro-Urol Mon. 2020;12(4):e107859. doi: https://doi.org/10.5812/numonthly.107859
Aliakbarian M, Ghasemzadeh Rahbardar M, Barzegar Torghabeh Z, Faghani G, Khodashahi R. Latent Tuberculosis Management in Liver Transplant Recipients: Insights from a Retrospective Analysis. Arch Clin Infect Dis. 2025;20(5):e158129. doi: https://doi.org/10.5812/archcid-158129
Shahbazi N, Haeri H, Nasiri Toosi M, Jafarian A, Shahsiah R, et al. Correlation of Histopathologic Findings of Non-Graft Threatening Preservation/Reperfusion Injury in Time-Zero Liver Needle Biopsies With Short-Term Post-transplantation Laboratory Alterations. Hepat Mon. 2015;15(6):e30008. doi: https://doi.org/10.5812/hepatmon.30008v2
Hosseini M, Rostami Z, Einollahi B. Dyslipidemia After Kidney Transplantation and Correlation With Cyclosporine Level. Nephro-Urol Mon. 2013;5(3):. doi: https://doi.org/10.5812/numonthly.11890
Last Update: 2 weeks ago
Last Update: 2 weeks ago
Last Update: 2 weeks ago
Last Update: 1 day ago